October 28, 2015 FDA approves Amgen's injected immunotherapy for melanoma U.S. health regulators on Tuesday approved Amgen Inc's novel cancer immunotherapy for injection into melanoma lesions and lymph nodes of patients with the deadliest form of skin cancer that returns after initial surgery.
October 28, 2015 Party drug Ketamine could help treat severe depression The party drug ketamine could one day be used to help some people suffering from severe depression, according to British scientists who gave infusions of the narcotic nicknamed "special K" to patients.
October 28, 2015 Study finds potential treatment for deadly brain cancer that killed Ted Kennedy Glioblastoma mutliforme (GBM) is one of the deadliest types of brain cancer, killing approximately 13,000 people every year – including Sen. Ted Kennedy in 2009.
October 28, 2015 Following child deaths fentanyl pain patches to be relabeled Companies that make fentanyl pain patches are being required to change the writing on the products so they can be seen more easily, after two more children who were accidentally exposed to the patches died.
October 28, 2015 FDA OKs first drug for morning sickness in more than 50 years U.S. health regulators have approved a drug to treat morning sickness that was withdrawn from the market 30 years ago amid claims, since debunked, that it caused birth defects
October 28, 2015 New experimental vaccine may treat common strains of norovirus An experimental vaccine created by Takeda Pharmaceutical Company has found to be effective in treating common strains of the norovirus – a contagious disease that causes stomach pain, nausea and diarrhea.
October 28, 2015 Daily vitamin D supplement may prolong remission from Crohn’s disease, study finds Crohn’s disease, a condition marked by inflammation in the lining of the digestive tract, can cause diarrhea, fatigue, weight loss and malnutrition, and affects an estimated 201 out of 100,000 American adults, according to the Centers for Disease Control and Prevention (CDC).
October 28, 2015 Novartis launches chronic disease program for poor countries Drugmaker Novartis AG has begun a program in Kenya, Ethiopia and Vietnam to supply 15 low-cost medicines to fight chronic diseases like diabetes and high blood pressure.
October 28, 2015 Weight-loss drugs seek acceptance from patients and physicians A new generation of weight-loss medications that suppress patients’ appetites and make them feel full is facing reluctance among patients because of safety issues with past diet drugs.
October 28, 2015 Families on Medicaid make more incorrect assumptions about antibiotics Parents of children insured by Medicaid, the U.S. health program for the poor, are more likely to incorrectly assume antibiotics can treat colds and flu and seek these drugs when kids don’t actually need them, a study suggests.
